MDAI
Spectral AI, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.53
−2.55%Year over year
Reported trailing growth
- Revenue
- -45.0%
- EBITDA
- +28.6%
- EBIT
- —
- EPS
- +48.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -44.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.2%
- EBITDA
- +52.8%
- EBIT
- -30.7%
- Net income
- +50.6%
- EPS
- +65.9%
- Free cash flow
- -7.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026